Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CALCITONIN for Hyperparathyroidism primary: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where CALCITONIN was used for Hyperparathyroidism primary.

Most Reported Side Effects for CALCITONIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 178 44.0% 12 101
Maternal exposure during pregnancy 49 12.1% 0 21
Hypercalcaemia 40 9.9% 1 34
Exposure during pregnancy 39 9.6% 1 15
Fatigue 36 8.9% 0 33
Poor quality sleep 32 7.9% 0 32
Foetal exposure during pregnancy 31 7.7% 0 6
Impaired quality of life 29 7.2% 0 29
Impaired work ability 29 7.2% 0 29
Hypocalcaemia 27 6.7% 1 15
Nausea 25 6.2% 2 14
Off label use 25 6.2% 0 11
Premature baby 25 6.2% 0 5
Premature delivery 23 5.7% 0 4
Hypertension 20 4.9% 0 19

Other Indications for CALCITONIN

Hypercalcaemia (219) Product used for unknown indication (50) Complex regional pain syndrome (32) Osteoporosis (27) Hypercalcaemia of malignancy (10)

Other Drugs Used for Hyperparathyroidism primary

CINACALCET (510) DENOSUMAB (86) SENSIPAR (14) FUROSEMIDE (11) ZOLEDRONIC ACID (10) CALCITONIN SALMON (8) EVOCALCET (6) MIMPARA (6) SODIUM (5)

Related Pages

CALCITONIN Full Profile All Hyperparathyroidism primary Drugs CALCITONIN Demographics CALCITONIN Timeline